Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study.
- DOI
- 10.1002/oby.70106
- Published
- 2026 Mar
- Container
- Obesity (Silver Spring, Md.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/oby.70106,
title = {Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study.},
author = {Bays HE and Toth P and Alkhouri N and Pullman J and Freilich B and Neutel J and Ji S and Stubbe S and Hedges P and Lian B},
year = {2026},
journal = {Obesity (Silver Spring, Md.)},
doi = {10.1002/oby.70106},
url = {https://doi.org/10.1002/oby.70106}
}RIS
TY - JOUR TI - Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study. AU - Bays HE AU - Toth P AU - Alkhouri N AU - Pullman J AU - Freilich B AU - Neutel J AU - Ji S AU - Stubbe S AU - Hedges P AU - Lian B PY - 2026 JO - Obesity (Silver Spring, Md.) DO - 10.1002/oby.70106 UR - https://doi.org/10.1002/oby.70106 ER -
APA
HE, B., P, T., N, A., J, P., B, F., J, N., S, J., S, S., P, H., & B, L. (2026). Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study.. Obesity (Silver Spring, Md.). https://doi.org/10.1002/oby.70106
Source records
- pubmed · retrieved 2026-09-27T12:05:00.160Z